Clinical Trial Update: Glycemic Effect of Diazoxide in NAFLD [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the glycemic effects of diazoxide in individuals with hyperinsulinemia, insulin resistance, prediabetes, and non-alcoholic fatty live…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperinsulinemia
• Insulin Resistance
• Non-alcoholic Fatty Liver Disease
• Prediabetes

Drugs mentioned

• DIAZOXIDE (DIAZOXIDE)

Snippet

Sponsor: Columbia University | Conditions: Hyperinsulinemia, Insulin Resistance | Phase 1 | Status: COMPLETED